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Immunobiotics have emerged as a promising intervention to alleviate intestinal damage
in inflammatory bowel disease (IBD). However, the beneficial properties of immunobiotics
are strain dependent and, therefore, each strain has to be evaluated in order to
demonstrate its potential application in IBD. Our previous in vitro and in vivo studies
demonstrated that Lactobacillus jensenii TL2937 attenuates gut acute inflammatory
response triggered by Toll-like receptor 4 activation. However, its effect on colitis
has not been evaluated before. In this work, we studied whether the TL2937 strain
was able to protect against the development of colitis in a dextran sodium sulfate
(DSS)-induced mouse model and we delved into the mechanisms of action by
evaluating the effect of the immunobiotic bacteria on the transcriptomic response
of DSS-challenged intestinal epithelial cells. L. jensenii TL2937 was administered to
adult BALB/c mice before the induction of colitis by the administration of DSS.
Colitis and the associated inflammatory response were evaluated for 14 days. Mice
fed with L. jensenii TL2937 had lower disease activity index and alterations of
colon length when compared to control mice. Reduced myeloperoxidase activity,
lower production of pro-inflammatory (TNF-α, IL-1, CXCL1, MCP-1, IL-15, and IL-17),
and higher levels of immunoregulatory (IL-10 and IL-27) cytokines were found in
the colon of TL2937-treated mice. In addition, the treatment of porcine intestinal
epithelial (PIE) cells with L. jensenii TL2937 before the challenge with DSS differentially
regulated the activation of the JNK pathway, leading to an increase in epithelial
cell integrity and to a differential immunotranscriptomic response. TL2937-treated
PIE cells had a significant reduction in the expression of inflammatory cytokines
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(TNF-α, IL-1α, IL-1β, IL-6, IL-15), chemokines (CCL2, CCL4, CCL8, CXCL4, CXCL5,
CXCL9, CXCL10), adhesion molecules (SELE, SELL, EPCAM), and other immune factors
(NCF1, NCF2, NOS2, SAA2) when compared to control cells after the challenge with
DSS. The findings of this work indicate that (a) L. jensenii TL2937 is able to alleviate
DSS-induced colitis suggesting a potential novel application for this immunobiotic strain,
(b) the modulation of the transcriptomic response of intestinal epithelial cells would play
a key role in the beneficial effects of the TL2937 strain on colitis, and (c) the in vitro
PIE cell immunoassay system could be of value for the screening and selection of new
immunobiotic strains for their application in IBD.
Keywords: immunobiotics, intestinal inflammation, Lactobacillus jensenii TL2937, PIE cells,
immunotranscriptomic response
INTRODUCTION
Inflammatory bowel disease (IBD), which includes Crohn’s
disease (CD) and ulcerative colitis (UC), is characterized by a
chronic inflammation of the gastrointestinal tract (1, 2). Complex
interactions between the environment, the gut microbiota, and
the mucosal immune system in genetic-susceptible hosts have
been implicated in the development and progress of IBD (3).
Human clinical trials and IBD animal models have established
that the breakdown of the cytokine networks that regulate the
epithelial barrier function, the interaction of microbes with
the immune system, and tissue repair are key players in the
development of IBD (4). The great progress in the understanding
of the intestinal cytokine networks that either suppress or
promote gut inflammation has allowed the development of
several preventive or therapeutic strategies based on cytokine
regulation that are effectively used or are being evaluated
in the clinic [reviewed in (2)]. Both the enhancement of
immunoregulatory cytokines to prevent inflammation and the
blockade of pro-inflammatory cytokine pathways have been
shown to be effective in the treatment of IBD (1, 2).
Molecular and genomic studies in mouse models and in large
IBD patient cohorts are revealing the role of several cytokine
and their cellular pathways in the intestinal inflammatory
damage, and therefore, many potential alternative cytokine-based
therapies are being explored. Of interest, most of these cytokine-
based therapies have focused their attention in the modulation
of one single factor (1). The therapies based on the blockade
of tumor necrosis factor (TNF)-α, which is effective in the
majority of the IBD patients, is currently used as a standard
therapy in the clinic (2). In patients with no response to TNF-
α treatment, the blockade of other pro-inflammatory cytokines
was effective in controlling inflammation. In this regard, the
blockade of interleukin (IL)-6 (5), IL-1, or IL-18 (6, 7) is able to
ameliorate colitis in IBD patients. Of note, despite the extensive
research demonstrating the role of IL-17 and interferon (IFN)-
γ in promoting inflammation in the gut of IBD patients or
the protective role of IL-10, the blockade of IL-17A (8) or
IFN-γ (9) as well as the systemic administration of IL-10 (10,
11) has not been beneficial in IBD. In addition, considering
that most cytokines have a plethora of different roles and that
the mentioned treatments are administered systemically, several
non-desired side effects have been described for single cytokine-
based therapies (1, 2). Perhaps the best example is the blockade of
IL-6 that was described to induce gastrointestinal abscesses and
perforation because of the key role of this cytokine in intestinal
epithelial cells (IECs) repair (5).
The delicate balance between the beneficial and detrimental
effects of cytokines as well as the complex interactions that
are established between them in the context of IBD makes it
necessary that the cytokine-based therapies are tightly controlled
in a spatial, temporal, and quantitative manner. Then, therapies
that canmodulate the profile of several cytokines simultaneously,
and that impact locally in the intestinal mucosa, would be
potentially more effective and present fewer adverse effects. In
this regard, extensive research has demonstrated that beneficial
microbes with immunomodulatory capacities (immunobiotics)
are able to differentially regulate intestinal cytokine profiles and,
therefore, to protect against the inflammatory damage in both
animal models and IBD patients (12, 13). Some of the most
widely studied immunobiotic strains such as Lactobacillus casei
Shirota, L. casei BL23, and Escherichia coli Nissle 1917 have
been shown to exert beneficial effects in animal models of IBD
by regulating cytokine profiles (12). On the other hand, other
well-characterized immunobiotic strains including L. acidophilus
NCFM (14) or L. rhamnosus GG (15) did not attenuate
symptoms. Furthermore, some probiotics such as L. crispatus
M206119 have been found to aggravate dextran sulfate sodium
(DSS)-induced colitis in mice (16). These findings highlight
the importance of accurately evaluating each immunobiotic
candidate to be used in IBD.
Lactobacillus jensenii TL2937 is an immunobiotic strain that
has been widely characterized by our group. Studies in porcine
intestinal epithelial (PIE) cells demonstrated the ability of the
TL2937 strain to inhibit nuclear factor κB (NF-κB) and mitogen-
activated protein kinase (MAPK) signaling pathways (17), and
to differentially regulate the expression levels of inflammatory
cytokines and chemokines (18) in the context of Toll-like
receptor (TLR)-4 activation. In addition, the TL2937 strain is
capable of regulating the expression of activation markers and
cytokine production in antigen-presenting cells from porcine
Peyer’s patches after the activation of TLR4 (19, 20). These in
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vitro findings prompted us to evaluate the immunoregulatory
effects of L. jensenii TL2937 in vivo. Therefore, by using a
porcine model we showed that the TL2937 strain improved
the growing performance and the productivity of piglets by
reducing the intestinal inflammation associated with weaning
(21). Considering the remarkable ability of L. jensenii TL2937 to
reduce inflammatory cytokines and to increase IL-10 in our in
vitro and in vivo models, we hypothesized that this strain could
exert beneficial effects in IBD. In this work, we studied whether
the TL2937 strain was able to protect against the development
of colitis in a DSS-induced mouse model. In addition, we delved
into the mechanisms of action by evaluating the effect of the
immunobiotic bacteria on the transcriptomic response of DSS-
challenged intestinal epithelial cells.
MATERIALS AND METHODS
Animals and Ethical Statement
Five-week-old female Balb/c mice were obtained from the
closed colony at CERELA (Tucumán, Argentina). Animals were
housed in plastic cages and environmental conditions were kept
constant, in agreement with the standards for animal housing. All
efforts were made to minimize the number of animals and their
suffering. Animals were euthanized immediately after the time
point was reached. No deaths were observed before mice reached
the endpoints.
This study was carried out in strict accordance with
the recommendations in the Guide for the Care and
Use of Laboratory Animals of the Guidelines for Animal
Experimentation of CERELA. The CERELA Institutional
Animal Care and Use Committee prospectively approved this
research under the protocol BIOT-IBT4-18.
Immunobiotic Administration and
Induction of Colitis
The immunobiotic strain L. jensenii TL2937 was grown in MRS
medium (Difco, Detroit, MI) for 16 h at 37◦C (17, 19). Cultures
were kept freeze-dried and then rehydrated using the following
medium: tryptone, 10.0 g; meat extract, 5.0 g; peptone, 15.0 g;
and distilled water, 1 L, pH 7. Bacteria were cultured for 12 h
at 37◦C (final log phase) in Man–Rogosa–Sharpe broth (MRS,
Oxoid, Cambridge, UK). Lactobacilli were harvested through
centrifugation at 3,000 × g for 10min and washed 3 times with
sterile 0.01 mol/L phosphate buffer saline (PBS), pH 7.2, and
suspended in sterile 10% non-fat milk for administration to
mice (22).
L. jensenii TL2937 was administered to different groups of
mice before and/or during the induction of colitis as shown
in Figure 1A. Mice were deprived of water for 4 h, and the
immunobiotic strain was given at a dose of 108 cells/mouse/day
in a minimum volume of drinking water to animals in individual
cages (22). Control mice were treated with water containing
only non-fat milk. The lactobacilli-treated groups and the
control mice were fed a conventional balanced diet ad-libitum
during experiments.
Acute colitis was established using a previously established
method (23). Briefly, mice were administered 2.5% (w/v) DSS
36–50 kDa (Thermo Fisher Scientific, USA) in drinking water
ad-libitum for 7 days (Figure 1A). DSS was given to mice after
3 h of lactobacilli administration. Mice were examined daily for
body weight, general appearance (piloerection and lethargy),
stool consistency, and the presence of fecal blood. The animals
were sacrificed at different time points (days −1, 1, 7, and 14, of
Figure 1A) and fasted for 12 h prior to sacrifice.
Disease Activity Index and Clinical Score
For the evaluation of the impact of L. jensenii TL2937
and DSS administration in the health of mice, two scores
were calculated based in the observations performed by two
different groups of qualified personnel: the disease activity
index (DAI) (23, 24) and the clinical score (25). DAI
was calculated considering the weight loss percentage, the
presence of fecal blood, and stool consistency. DAI values
were calculated as [(weight loss score) + (stool consistency)
+ (rectal bleeding score)]/4 and scored on a 0 ± 4 scale
(Supplementary Table 1). The intensity of general appearance,
weight loss, stool consistency, and rectal bleeding was graded
to create a clinical score for the colitis ranging from 0 to 14
(Supplementary Table 1).
Cytokine Concentrations
The determination of cytokine concentration in colon was
performed following the method described by Rodrigues
et al. (25). Tissue samples (100mg) were collected from
the distal portion of the colon and homogenized in
1ml of PBS containing protease inhibitors (0.1mM
phenylmethylsulfonyl fluoride, 0.1mM benzethonium chloride,
10mM ethylenediaminetetraacetate, 20 KI aprotinin A, and
0.05% Tween 20) and centrifuged for 15min at 3,000 × g.
Blood samples were obtained by cardiac puncture under
anesthesia as described previously (26). Intestinal fluid samples
were obtained according to Albarracin et al. (27). Briefly,
the small intestine was flushed with 5ml of PBS and the
fluid was centrifuged (10,000 g, 4◦C for 10min) to separate
particulate material.
Tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-
6, IL-10, IL-15, IL-17, IL-27, transforming growth factor
(TGF)-β, interferon (IFN)-γ, chemokine KC (or CXCL1), and
monocyte chemoattractant protein-1 (MCP-1) concentrations in
colon tissue were measured with commercially available mouse
enzyme-linked immunosorbent assay (ELISA) technique kits
following the manufacturer’s recommendations (R&D Systems,
MN, USA or Abcam, San Francisco, USA).
Caco-2 cell supernatants were collected after the treatments
described below. TNF-α, IL-1β, IL-6, and IL-8 were measured
with commercially available human ELISA technique kits
following the manufacturer’s recommendations (Abcam, San
Francisco, USA).
Myeloperoxidase (MPO) Assay in Colon
Tissue
Neutrophil infiltration in the colon tissue was quantified
indirectly by measurement of MPO. Colon sections were
cleared of debris, washed in PBS, and weighed. Samples were
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FIGURE 1 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the colitis induced in mice by dextran sodium sulfate (DSS) administration. (A) L. jensenii TL2937
was orally administered to different groups of mice (108 cells/mouse/day) before (PRE DSS+TL2937 group), simultaneously (SIM DSS+TL2937 group), or
continuously (CONT DSS+TL2937 group) with the administration of DSS for 7 days. Untreated mice challenged only with DSS were used as controls. The animals
were sacrificed at different time points: the end of immunobiotic administration (day −1), the start of DSS administration (day 1), the end of DSS administration (day 7),
and 7 days after the last DSS administration (day 14). (B) Body weight change was monitored daily during the study period. (C) Colon length, (D) colon length:weight
ratio, (E) disease activity index, and (F) clinical scores were evaluated at the indicated days. The results represent three independent experiments. Significant
differences when compared to the DSS control group: *P < 0.05.
homogenized in 50mM acetate buffer, pH 5.4 (MPO-assay
buffer). Homogenates were frozen at −70◦C for 20min, thawed,
sonicated for 50 s, and centrifuged at 3,600 × g for 15min at
4◦C. MPO was evaluated by adding 200ml of an appropriate
dilution of the lysate to 20mM 3,30,5,50-tetramethylbenzidine in
dimethylformamide and 30ml of 2.7mM of hydrogen peroxide
in MPO-assay buffer. The reaction mixture was incubated for
5min at 37◦C and stopped with ice-cold 200mM sodium acetate
buffer (pH 3) (26). Absorbance was read at 650 nm against a
standard curve made with commercial MPO (Sigma). The results
were expressed as specific activity of MPO (MPO units/g of
colon homogenate).
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Human and Porcine Intestinal Epithelial
Cells
The porcine intestinal epithelial (PIE) cell line was originally
established by our group (28). PIE cells were isolated from
intestinal epithelia derived from an unsuckled neonatal piglet.
The PIE cells were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM) enriched with 10% fetal calf serum (FBS), 100
U/ml penicillin, and 100 mg/ml streptomycin (Gibco, Thermo
Fisher Scientific Co.) and plated into collagen (Type III)-coated
250ml flask (Sumilon, Tokyo, Japan). After reaching confluence,
the plate was washed twice with PBS and treated with the
buffer containing 0.1MNa2HPO4 12H2O, 0.45M sucrose, 0.36%
EDTA 4 Na, and BSA at 37◦C for 5min. Then, PIE cells were
treated with a trypsin solution containing 0.25% trypsin and
0.02% EDTA in PBS at 37◦C for 3min, and the cells were
collected by centrifugation (1,000 × g for 5min at 4◦C). After
counting their numbers, PIE cells were seeded in a new flask,
and after overnight culture, the supernatant was removed and
fresh DMEM was added for a subsequent culturing. At least
three consecutive passages were performed before the challenge
experiments were conducted.
Human epithelial Caco-2 cells were grown in DMEM
supplemented with 10% FBS, 50 U/ml penicillin, and 50 mg/ml
streptomycin and maintained at 37◦C in a humidified chamber
of 5% CO2.
Immunomodulatory Effect of L. jensenii
TL2937 in PIE Cells
PIE cells were seeded at 3 × 104 cells per well in 12-well type
I collagen-coated plates (Sumitomo Bakelite Co., Tokyo, Japan)
and cultured for 3 days as explained before. After changing the
medium, L. jensenii TL2937 (5 × 107 cells/ml) were added, and
48 h later, each well was washed vigorously with a medium at
least three times to eliminate all stimulants. Then, cells were
stimulated with DSS 5,000 Da (Wako Pure Chemical Industries
Ltd., Osaka, Japan), dissolved in DMEM, and sterilized using
DISMIC 25AS 0.45µm (ADVANTEC, Tokyo, Japan). Different
concentrations of DSS (0.1, 0.01, 0.001, and 0.0001%) were
used for cytotoxicity assay (29). Viability was measured by a
commercially available kit (Cell Titer 96TM AQueous, Promega,
Madison, USA), which depends on the physiologic reduction of
MTS to formazan. DSS 0.01% was used for the evaluation of
transepithelial electrical resistance, western blot, qRT-PCR, and
microarray studies. Caco-2 cells were seeded at 3 × 104 cells per
well in 12-well type I collagen-coated plates and treated with L.
jensenii TL2937 as described for PIE cells. After 48 h, Caco-2 cells
were stimulated with 1% of DSS (29) and inflammatory factors
were evaluated by ELISA.
Two-Step Real-Time Quantitative PCR
(qRT-PCR)
Total RNA was isolated from each cell sample using TRIzol
reagent (Invitrogen). Briefly, 100 µl of chloroform was added
to samples and stirred. After 3min standing, samples were
centrifuged at 15,000 rpm, 15min, 4◦C. The upper layer (water
layer) was collected andmixed with same amount of isopropanol.
After standing for 10min, samples were centrifuged at 15,000
rpm, 15min, 20◦C. The supernatants were eliminated, and the
pellets were washed with 75% ethanol. After centrifugation
(15,000 rpm, 15min, 4◦C), the supernatants were eliminated and
pellets were dried at 50◦C in a block incubator. Then, samples
were diluted with DEPC water. Concentration and purity
ware measured by a NanoDrop ND-1000 Spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, NC, USA).
DNAs were synthesized using a QuantiTect reverse
transcription (RT) kit (Qiagen, Tokyo, Japan) according
to the manufacturer’s protocol. Real-time quantitative
polymerase chain reaction (PCR) was performed with an
Applied Biosystems Real-Time PCR System 7300 (Applied
Biosystems, Warrington, United Kingdom) and the Platinum
SYBR Green qPCR SuperMix-UDG (uracil-DNA glycosylase)
with ROX (6-carboxyl-X-rhodamine) (Invitrogen). The primers
for porcine immune factors, and β-actin is provided in
Supplementary Table 2 or is described previously (18, 30). The
PCR cycling conditions were 5min at 50◦C, followed by 5min at
95◦C, and then 40 cycles of 15 s at 95◦C, 30 s at 60◦C, and 30 s at
72◦C. The reaction mixtures contained 2.5 µl of sample cDNA
and 7.5 µl of master mix, which included the sense and antisense
primers. According to the minimum information for publication
of quantitative real-time PCR experiment guidelines, β-actin was
used as a housekeeping gene because of its high stability across
porcine various tissues (18, 30). Expression of porcine β-actin
was used to normalize cDNA levels for differences in total cDNA
levels in the samples.
The expressions of tight junctions and adherens junctions
genes including occluding (Ocln), zonula occludens 1 (ZO-1),
claudin 1 (Cldn1), and β-catenin (Ctnn) were evaluated by qRT-
PCR in colon sections of mice. Tissue samples were cleared of
debris, washed in sterile PBS, and weighed. RNA was extracted
from the colon tissue samples using TRIzol reagent (Invitrogen,
USA). The primers for murine tight junctions, adherens
junctions, and β-actin are provided in Supplementary Table 2.
The reaction mixtures contained 5 µl SYBR Premix Ex TaqTM II
(5×), 0.2 µl Rox, 0.5 µl primer mix (10µM), and 0.5 µl cDNA.
The PCR cycling conditions were 30 s at 95◦C, 40 cycles of 95◦C
for 5 s, and 60◦C for 30 s. The expression of murine β-actin was
used to normalize cDNA levels for differences in total cDNA
levels in the samples.
Assessment of Intestinal Epithelial Barrier
Function
Transepithelial electrical resistance (TER) was used as a measure
of barrier function in confluent PIE cell monolayers after the
challenge with 5,000 Da DSS. For growth on porous filters, PIE
cells were grown in the DMEM and plated at 1.0 × 106 cells on
a 0.4-µm PTFE membrane (Corning, NY, USA). Cellular TEERs
were measured with an electrical resistance system,Millicell ERS-
2 Voltohmmeter (Merck Millipore, Massachusetts, USA). Cells
with stable TER readings >500 øcm were used (4–5 weeks post
plating). To evaluate the stimulus effect on the epithelial barrier,
TEER was measured at baseline and after 48 h of stimulation. The
blank measurements (transwell without cell monolayer) were
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subtracted from TEER values of each experimental condition and
were adjusted for the filter surface (0.3 cm2). The values were
expressed as ohms per cm2. The results represent the percentage
of final TER increases with respect to their basal TER value.
Apoptosis Evaluation
The GFP-CERTIFIED Apoptosis/Necrosis detection kit (Enzo
Life Sciences, Farmingdale, NY, USA) was used to evaluate
apoptosis in DSS-challenged PIE cells. The cells (6.0 × 104
cells/2ml) were seeded into a Celtite C-1 Collagen-coated 6-well
plate (SUMILON, Tokyo, Japan) and cultured at 37◦C, 5% CO2.
Apoptosis-positive controls were generated by the treatment of
PIE cells with 1mM of staurosporine for 4 h. After stimulations,
1ml of epithelial buffer was added to each well and incubated for
3min. Cells were detached by adding 500 µl of trypsin for 1min
and centrifugation at 800 rpm for 5min. The cell pellets were
washed with PBS, mixed with Dual Detection Regent, and kept
at room temperature for 15min in the dark. The measurement
was performed with BD Accuri C6 Plus (BD, New Jersey, USA)
and analyzed with FLOWJO (FLOWJO, Oregon, USA).
The caspase 3/7 was evaluated by using the CellEvent Caspase-
3/7 Green Flow Cytometry Assay Kit (Thermo Fisher Scientific,
Massachusetts, USA). PIE cells (6.0× 104 cells/2ml) were treated
with 1 µl of CellEvent Caspase-3/7 Green Detection Reagent and
incubated at 37◦C for 25min in the dark. Then, 1 µl of SYTOX
AADvanced reagent was added and incubated at 37◦C for 5min
in the dark. The measurement was performed with BD Accuri
C6 Plus (BD, New Jersey, USA) and analyzed with FLOWJO
(FLOWJO, Oregon, USA).
Western Blot Analysis
PIE cells were stimulated with L. jensenii TL2937 (5.1 × 108
cells/well) for 48 h. Then, the cells were washed three times
with DMEM medium to eliminate the bacteria and subsequently
challenged with 0.1% of DSS for 0, 10, 20, 30, and 60min. The
PIE cells were washed and resuspended in 200 µl of CelLytic
M Cell Lysis Reagent (Sigma-Aldrich, St. Louis, MO, USA),
containing protease and inhibitors of phosphates (Complete
mini, PhosSTOP, Roche, Mannheim, Germany). Cells were
transferred to 1.5-ml Eppendorf tubes and kept at 95◦C for 5min
in a water bath. The concentration of protein was estimated
using BCA assay kit (Pierce, Rockford, IL). The lysed samples
(8 µg/sample) were loaded on 10% SDS-polyacrylamide gels,
and separated proteins were transferred electrophoretically to
a nitrocellulose membrane. The cells were rinsed with PBS
and then lysed in RIPA buffer (PBS, 1% Nonidet P-40, 0.5%
sodium deoxycholate, and 0.1% SDS) with a protease inhibitor
cocktail (Sigma Chemical Co.) at 4◦C. Total cell lysates were
separated with 8% SDS–polyacrylamide gel electrophoresis and
transferred to PVDF membrane. Jun N-terminal protein kinase
(JNK) was evaluated using anti-phosphated JNK antibodies
(Santa Cruz Biotech). Blots were developed using ECL Western
blotting detection reagent kit (Amersham Pharmacia Biotech,
Inc., Piscataway, NJ). The optical protein bands were detected
by ECF substrate (GE Healthcare Japan Co., Tokyo, Japan) and
estimated from the peak area of densitogram by using ImageJ
software (National Institutes of Health, Bethesda, MD, USA).
Intracellular Ca2+ Flux in PIE Cells
Intracellular calcium mobilization was measured using the Fluo-
4 DirectTM Calcium Assay Kits from Invitrogen according to
the manufacturer’s instructions (Dojindo, Kumamoto, Japan)
as described previously (31). Briefly, PIE cells were plated
in 96-well white-walled plates and grown to 90% confluence.
Cells were serum-starved overnight and loaded with cell-
permeant Fluo-4-AM diluted in calcium-free Hanks’ balanced
salt solution supplemented with 20mm HEPES buffer provided
by the manufacturer. Intracellular calcium flux was measured by
fluorescence spectroscopy every 5 s for a total of 220 s (Victor2
Wallac, PerkinElmer Life Sciences). Background fluorescence
was measured 30 s before addition of DSS and the average
background subtracted from each value.
Immunofluorescence
PIE cells (1.0 × 106) were seeded on a Transwell 6.5-mm-
inserted, collagen-coated 0.4-µmPTFEmembrane (Corning, NY,
USA) and cultured for 8 days. Then, PIE cells were stimulated
with L. jensenii TL2937 (5× 107 cells/ml) for 48 h and challenged
with 0.1% DSS for 6 h. The Transwell was washed with PBS
and fixed with 4% paraformaldehyde phosphate buffer (room
temperature, 20min). Thereafter, the plate was washed with PBS
and blocked with 2% goat serum (room temperature, 20min).
After washing with PBS-Tween, 50 µl of Can Get Signal Solution
1 was added to each well, and 1 µl of anti-ZO-1 or anti-β-catenin
was added to make a 50-fold dilution. It was left overnight at 4◦C,
protected from light. After washing with PBS-Tween, 500 µl of
Can Get Signal Solution 2 and 0.5 µl of Alexa Flour 488 were
added (×1,000). The plate was allowed to stand for 2 h in the
shade and washed with PBS-Tween. The membrane was excised
with scissors for dissection, sealed with a mounting medium
containing DAPI, dried overnight in a vat, and observed with
OLYMPUS IX70 (OLYMPUS, Tokyo, Japan).
RNA Isolation and Quality Control for
Microarray Analysis
Total RNA was isolated from the ligand-treated and control PIE
cells using PureLink RNA Mini Kit (Life Technology Inc., USA)
along with on-column DNase treatment (18, 30). RNA integrity,
quality, and quantity were evaluated with microcapillary
electrophoresis (2100 Bioanalyzer, Agilent Technologies, Santa
Clara, CA, USA) using the Agilent RNA 6000 Nano Kit (Agilent
Technologies, Santa Clara, CA, USA). Only samples with an
RNA integrity number (RIN) of >8 were used for this gene
expression study.
Microarray Hybridization
The microarray hybridization was performed with a Porcine
Gene Expression Microarray 4× 44K oligonucleotide slide (v2.0,
Agilent Technologies, Santa Clara, CA, USA) containing 43,803
probes for the identification of known genes of the porcine
transcriptome. The microarray experiment was conducted at
Hokkaido System Science Co., according to the one-color
Microarray-Based Gene Expression Analysis Protocol v6.7
(Agilent Technologies, Santa Clara, CA, USA). For each sample,
200 ng of total RNA was converted into cDNA by reverse
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transcription. The cDNA was subsequently transcribed into
cRNA and labeled with cyanine 3 (Cy3). About 1.65 µg of labeled
cRNA was mixed with hybridization buffer and hybridized on a
microarray slide (4 samples in each slide) for 17 h at 65◦C with
constant rotation. After hybridization, microarrays were cleaned
with Gene Expression Wash Buffer and scanned with High-
Resolution Microarray Scanner (Agilent Technologies, Santa
Clara, CA, USA). The Feature Extraction software (v10.7.3.1,
Agilent Technologies, Santa Clara, CA, USA) was used for
detailed analysis of scanned images including filtering the
outlier spots, background subtraction from features, and dye
normalization. The spot intensity data for individual sample were
extracted for statistical analysis.
Statistical Analysis of Microarray Data
The normalization and differential expression analysis of
microarray data were performed with GeneSpring GX software
(v13.1, Agilent Technologies, USA). The log2-transformed
expression values of probes were normalized based on 75
percentile shifts. In order to determine the differential expression
of genes, an unpaired t-test was performed between untreated
control and stimulated samples. The pair-wise comparisons were
performed between control and each of the stimulations to
detect the differentially expressed genes. The Benjamini and
Hochberg (B-H) adjustment method was applied for multiple-
test correction. Significant differentially expressed genes were
selected on the basis of two criteria: an adjusted p-value (FDR,
false discover rate) of <0.05 and a cutoff in fold change of at
least 1.5 (18, 30). The human ortholog gene symbol of DEGs was
determined using the dbOrtho panel of the bioDBnet tool (32)
which was used for downstream functional analysis.
Network Enrichment Analyses
In order to visualize the L. jensenii TLR2937-mediated
immunotranscriptional network in DSS-challenged PIE
cells as well as to identify the regulatory genes, the subnetwork
enrichment analysis was performed using the NetworkAnalyst
online tool (33). This tool uses the InnateDB protein–protein
interaction datasets composed of 14,755 proteins and 145,955
literature-curated interactions for humans (34). Human
orthologous gene symbols of the common DEGs from all three
stimulation were uploaded into the NetworkAnalyst to construct
the interaction network based on the Walktrap algorithm
taking only direct interaction of seed genes. The network was
depicted as nodes (circles representing genes) connected by
edges (lines representing direct molecular interactions). Two
topological measures such as degree (number of connections
to the other nodes) and betweenness (number of shortest paths
going through the nodes) centrality were taken into account for
detecting highly interconnected genes (Hubs) of the network.
Nodes having a higher degree and betweenness were considered
as potentially important Hubs in the cellular signal trafficking.
Statistical Analysis
For in vivo experiments, each experimental group consisted of
three mice per group at each time point and experiments were
performed in triplicate (n = 9 for each parameter studied).
Results were expressed as mean ± standard deviation (SD).
The differences between groups were analyzed using the student
t-test. Differences were considered significant at P < 0.05
and P < 0.01. ANOVA one-way was used for analysis of
variance among multiple groups. For in vitro experiments, the
statistical analysis was performed using GLM procedures of
the SAS computer program. Mean values of relative mRNA
expression were compared using the Bonferroni correction and
multicomparison tests. Differences were considered significant
at P < 0.05.
RESULTS
L. jensenii TL2937 Alleviates DSS-Induced
Colitis in vivo
We first aimed to evaluate whether the oral administration of the
immunobiotic strain L. jensenii TL2937 was capable of avoiding
or reducing the intestinal inflammatory damage induced by
the DSS administration. For this purpose, three lactobacilli
treatment schemes were assessed as shown in Figure 1A.
The TL2937 strain was orally administered to mice before
(PRE DSS+TL2937 group), simultaneously (SIM DSS+TL2937
group), or continuously (CONT DSS+TL2937 group) with the
administration of DSS. The body weight change was used to
evaluate the general health status of TL2937- and DSS-treated
mice when compared with controls that received only DSS
(Figure 1B). Similar to DSS control animals, mice in the SIM
DSS+TL2937 group presented a gradual and continuous loss
of body weight throughout the period studied. Mice in the
PRE DSS+TL2937 and CONT DSS+TL2937 groups showed
decreases in body weights that were similar to those observed in
controls during the first 6 days after the administration of DSS.
However, these groups of TL2937-treated mice started to recover
body weights and showed values of this parameter that were
significantly higher than controls from days 7 to 14 (Figure 1B).
The colon length and the colon length:weight ratio were
evaluated to determine the severity of colitis (Figures 1C,D).
As expected, no significant differences were found in the values
of these parameters when control mice and the TL2937-treated
groups were compared before the administration of DSS (day
−1). In addition, no differences between the experimental groups
were detected on day 1 after DSS challenge. Similar to DSS
control animals, mice in the SIM DSS+TL2937 group had
reduced colon lengths and increased colon length:weight ratios
on days 7 and 14 after DSS administration (Figures 1C,D). On
the contrary, on days 7 and 14 the mice in the PRE DSS+TL2937
and CONT DSS+TL2937 groups showed significantly increased
colon lengths and decreased colon length:weight ratios when
compared to DSS controls (Figures 1C,D). To correlate the
general health status with the colon damage, we further evaluated
the disease activity index (DAI) and the clinical score on days
7 and 14 after DSS administration (Figures 1E,F). Both DAI
and clinical score values were similar in the SIM DSS+TL2937
group and control DSS mice. However, the PRE DSS+TL2937
and CONT DSS+TL2937 groups had DAI and clinical score
values that were significantly lower than the DSS control mice
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FIGURE 2 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the inflammatory response induced in mice by dextran sodium sulfate (DSS) administration. L.
jensenii TL2937 was orally administered to different groups of mice (108 cells/mouse/day) before (PRE DSS+TL2937 group), simultaneously (SIM DSS+TL2937
group), or continuously (CONT DSS+TL2937 group) with the administration of DSS for 7 days. Untreated mice challenged only with DSS were used as controls. The
animals were sacrificed at different time points: the end of immunobiotic administration (day −1), the start of DSS administration (day 1), the end of DSS administration
(day 7), and 7 days after the last DSS administration (day 14). (A) Colon myeloperoxidase (MPO) activity, (B) colon TNF-α, (C) serum TNF-α, and (D) small intestine
TNF-α were evaluated at the indicated days. The results represent three independent experiments. Significant differences when compared to the DSS control group:
*P < 0.05, **P < 0.01.
(Figures 1E,F). In particular, the absence of visible blood in
rectum or on fur was evident in PRE DSS+TL2937 and CONT
DSS+TL2937 mice.
L. jensenii TL2937 Differentially Regulates
the DSS-Triggered Inflammatory Response
in vivo
We next studied the effect of the immunobiotic treatments
on the inflammatory response triggered by the administration
of DSS. Since the increased production of TNF-α and the
infiltration of neutrophils have been described as key factors
in the inflammatory damage observed in DSS-induced colitis
(1, 2), we evaluated the colon MPO activity as an indirect marker
of neutrophil infiltration and the concentration of colon TNF-
α (Figures 2A,B). In addition, the levels of serum (Figure 2C)
and intestinal (Figure 2D) TNF-α were also determined. No
significant differences were found in the values of these four
parameters when control mice and the TL2937-treated groups
were compared before DSS administration (day −1) or on day
1 after the DSS challenge. However, significantly higher levels
of colon TNF-α and MPO activity as well as intestinal and
serum TNF-α were found in all the experimental groups at
days 7 and 14 after DSS administration when compared to day
1 (Figure 2). On days 7 and 14, no differences were observed
between the SIM DSS+TL2937 group and control DSS mice. On
the contrary, the PRE DSS+TL2937 and CONT DSS+TL2937
groups had significantly lower levels of colon MPO activity
and TNF-α in colon, intestine, and serum than control DSS
mice (Figure 2).
Considering that L. jensenii TL2937 was able to differentially
regulate the production of TNF-α in the colon and
diminished the recruitment of neutrophils, we selected the
PRE DSS+TL2937 treatment to further characterize the
immunomodulatory activity of the TL2937 strain by assessing
the levels of colon IL-1β, IL-6, IL-15, CXCL1, MCP-1, IFN-γ, IL-
17, TGF-β, IL-10, and IL-27 (Figure 3). The oral administration
of L. jensenii TL2937 to mice did not induce significant changes
in the levels of the colon cytokines evaluated before DSS
administration (day −1). In addition, no differences in the
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FIGURE 3 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the inflammatory response induced in mice by dextran sodium sulfate (DSS) administration. L.
jensenii TL2937 was orally administered to different groups of mice (108 cells/mouse/day) before (PRE DSS+TL2937 group) the administration of DSS for 7 days.
Untreated mice challenged only with DSS were used as controls. The animals were sacrificed at different time points: the end of immunobiotic administration (day −1),
the start of DSS administration (day 1), the end of DSS administration (day 7), and 7 days after the last DSS administration (day 14). (A) Colon inflammatory cytokines
and chemokines (IL-1β, IL-6, CXCL1, IL-15, MCP-1), (B) colon IFN-γ and IL-17, and (C) colon regulatory cytokines (TGF-β, IL-10, IL-27) were evaluated at the
indicated days. The results represent three independent experiments. Significant differences when compared to the DSS control group: *P < 0.05.
levels of colon pro-inflammatory cytokines were observed
when the day −1 and the day 1 after DSS administration were
compared, with the exception of IL-6 that were significantly
higher in the PRE DSS+TL2937 group (Figures 3A,B). All the
pro-inflammatory colon cytokines evaluated were increased
on days 7 and 14 after DSS administration when compared
to day 1 (Figures 3A,B). Interestingly, the concentrations
of the cytokines IL-1β and IL-6 and the chemokines IL-15,
CXCL1, and MCP-1 were significantly lower in the colon of PRE
DSS+TL2937 mice than in the DSS control group (Figure 3A).
The PRE DSS+TL2937 mice also had lower levels of colon
IFN-γ and IL-17 than DSS controls (Figure 3B). When the
immunoregulatory cytokines were analyzed, it was observed that
there were no differences in the levels of colon TGF-β between
days −1 and 1. On day 1, the levels of colon IL-10 and IL-27
were significantly higher in the PRE DSS+TL2937 group than
in DSS controls (Figure 3C). A decrease in IL-10 and IL-27 was
observed when days 7 and 14 were compared to day 1 in DSS
control mice. In addition, it was found that IL-10 and IL-27 were
significantly higher in the PRE DSS+TL2937 group than in the
DSS control group on days 7 and 14 after the challenge with DSS
while no differences between the groups were observed for colon
TGF-β concentrations (Figure 3C).
We also evaluated the effect of L. jensenii TL2937 in the
expression of Ocln, ZO-1, Cldn1, and Ctnn in the colon of mice
treated with DSS (Figure 4). No differences in the expression
levels of Ocln, ZO-1, Cldn1, and Ctnn were observed when
DSS controls and PRE DSS+TL2937 groups were compared to
basal controls in days −1 and 1 after DSS administration, with
the exception of ZO-1 that was significantly enhanced in mice
receiving the TL2937 strain. The DSS challenge reduced the
expressions ofOcln, ZO-1,Cldn1, andCtnn on days 7 and 14 after
its administration. Of note, mice in the PRE DSS+TL2937 group
had significantly higher levels of Ocln, ZO-1, and Ctnn on days
7 and 14 when compared to DSS controls. The only exception
was Cld1 that was not different when DSS controls and PRE
DSS+TL2937 groups were compared on day 7 (Figure 4). While
mice in the PRE DSS+TL2937 group had normal levels of Ocln
and Cldn1, the levels of ZO-1 and Ctnn were higher than basal
controls in days 7 and 14 after DSS administration.
L. jensenii TL2937 Diminishes DSS-
Triggered Epithelial Barrier Alterations
in vitro
Considering our previous studies demonstrating the ability
of L. jensenii TL2937 to differentially modulate inflammatory
responses in intestinal epithelial cells (17, 18), we hypothesized
that its beneficial effect in DSS-colitis in vivo could be related
to the modulation of the response of these cells to the challenge
with DSS. Then, we next aimed to characterize the effect of
L. jensenii TL2937 on intestinal epithelial cells in the context
of DSS-induced inflammatory damage. For this purpose, we
used as a model the PIE cell line developed by our group
(28). We reported previously that PIE cells show epithelial-like
morphology and create a monolayer attaching to neighboring
cells (28, 35, 36). These characteristics of PIE cells give us the
possibility of conducting in vitro studies to evaluate the epithelial
barrier function. We first evaluated the response of PIE cell
monolayers to the challenge with different concentrations of DSS
during 1, 3, or 6 h in terms of their viability (Figure 5A). A dose-
dependent effect was observed when the viability of PIE cells
was assessed after the challenge with the different concentration
of DSS. While no significant differences in cell viability were
induced by 0.0001% of DSS, the higher concentration (1%)
reduced PIE cell viability by 25%. No significant differences were
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FIGURE 4 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the inflammatory response induced in mice by dextran sodium sulfate (DSS) administration. L.
jensenii TL2937 was orally administered to different groups of mice (108 cells/mouse/day) before (PRE DSS+TL2937 group) the administration of DSS for 7 days.
Untreated mice challenged only with DSS were used as controls. The animals were sacrificed at different time points: the end of immunobiotic administration (day −1),
the start of DSS administration (day 1), the end of DSS administration (day 7), and 7 days after the last DSS administration (day 14). The expressions of occluding
(Ocln), zonula occludens 1 (ZO-1), claudin 1 (Cldn1), and β-catenin (Ctnn) were evaluated by qRT-PCR at the indicated days. The results represent three independent
experiments. Significant differences when compared to the DSS control group: *P < 0.05.
found when the 1, 3, and 6 h of stimulation were compared
within the same dose of DSS, with the exception of DSS 1%
for 6 h that induced the highest cell mortality (Figure 5A).
Considering those results, we selected 0.01% of DSS for 6 h for
further studies.
To evaluate the effect of L. jensenii TL2937, PIE cells were
treated with the bacteria, challenged with DSS and the viability
(Figure 5B) and the TER (Figure 5C) were evaluated. TL2937-
treated PIE cells had a significantly increased viability after the
challenge with DSS when compared to controls (Figure 5B). The
treatment of PIE cells with L. jensenii TL2937 did not induce
modifications in the TER index (Figure 5C). On the contrary,
DSS challenge diminished the TER index when compared
to unchallenged cells. Interestingly, TL2937-treated PIE cells
had normal TER index values after the stimulation with DSS
(Figure 5C). The barrier function of mucosal epithelial cells is
mediated mainly by the molecular structures that are established
between neighboring cells such as tight junctions and adherens
junctions. Then, we next evaluated the expression of ZO-1
(Figure 5D) and β-catenin (Figure 5E) in PIE cell monolayers
to study tight junctions and adherens junctions, respectively.
Immunofluorescence studies showed that both proteins are
mainly expressed in the cell–cell contact areas. The treatment of
PIE cells with DSS altered their expression of ZO-1 (Figure 5D)
and β-catenin (Figure 5E). An increased cytoplasmic expression
and an altered distribution on the cell surface of ZO-1 were
observed in DSS control PIE cells while TL2937-treated cells
showed a pattern of ZO-1 expression that was not different from
unchallenged cells (Figure 5D). DSS stimulation reduced both
cytoplasmic and cell surface expression of β-catenin. Although
the same reduction in β-catenin expression was observed in
TL2937-treated cells after DSS challenge, PIE cells in this group
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FIGURE 5 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the in vitro epithelial barrier alterations induced by dextran sodium sulfate (DSS) administration.
Porcine intestinal epithelia (PIE) were challenged with different concentrations of DSS for 1, 3, or 6 h for evaluation of (A) cell viability. The dose of 0.01% DSS for 6 h
was selected for further experiments. PIE cells were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h and then challenged with DSS. PIE cells challenged
only with DSS were used as controls. (B) Cell viability, (C) transepithelial electrical resistance (TER), (D) ZO-1 expression, and (E) β-catenin expression were
determined. TER index values before and after DSS challenge are indicated with white and black bars, respectively. The results represent three independent
experiments. Significant differences when compared to the unchallenged control group: *P < 0.05.
have some areas with accumulations of this protein both in the
cytoplasm and on their surface (Figure 5E).
The C-Jun N-terminal kinase (JNK) is an intracellular
signaling factor that has been reported to be activated in the
intestine of human IBD patients (37, 38). In particular, the
intracellular epithelial signaling mediated by Ca2+-Ask1-MKK7-
JNK2-c-Src cascade is involved in DSS-induced tight-junction
breakdown (39). Then, the activation of JNK (Figure 6A)
and intracellular Ca2+ mobilization (Figure 6B) were evaluated
in PIE cells challenged with DSS. It was observed that
the phosphorylated JNK (p-JNK) protein was increased in
control PIE cells between 10 and 20min (relative index of
4.1 in the peak) after DSS challenge (Figure 6A). The p-
JNK returned to basal levels after 30min in control DSS-
challenged PIE cells. In addition, DSS stimulation induced a
significant increase in intracellular Ca2+ fluxes in PIE cells
(Figure 6B). An earlier and lower increase (relative index
of 3.0 in the peak) in p-JNK levels (Figure 6A) as well
as lower intracellular Ca2+ fluxes (Figure 6B) were detected
in TL2937-treated PIE after DSS challenge when compared
to controls.
The phosphorylation of JNK in the intestinal epithelium
has been linked not only to the reduction of tight junctions
strength (39), but in addition to the expression of pro-
inflammatory cytokines such as IL-6 and TNF-α (40)
and the induction of apoptosis (41). Therefore, we also
evaluated the effect of DSS in the induction of apoptosis
in PIE cells. We performed flow cytometry studies using
Annexin V as a probe for phosphatidylserine on the outer
membrane of apoptotic cells (Figure 6C) as well as caspase
3/7 (Figure 6D). It was observed that DSS administration
significantly increased apoptotic cells when compared to
unchallenged controls. However, the apoptosis induced
by DSS was lower than that found in PIE cells treated
with the well-known apoptosis inductor staurosporine
(Figures 6C,D). Of note, the induction of apoptotic cells
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FIGURE 6 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the in vitro epithelial barrier alterations induced by dextran sodium sulfate (DSS) administration.
Porcine intestinal epithelia (PIE) were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h and then challenged with 0.01% DSS for 6 h. PIE cells challenged
only with DSS were used as controls. (A) JNK and phosphorylated JNK (p-JNK) levels, (B) Ca+2 influx, (C) apoptosis, and (D) caspase 3/7 expression were
determined in PIE cells after the challenge with DSS. The results represent three independent experiments. Significant differences when compared to the
unchallenged control group: *P < 0.05, **P < 0.01.
by DSS in TL2937-treated PIE cells was significantly lower than
that of DSS controls and resembled that found in unchallenged
PIE cells when Annexin V was used (Figure 6C). However, no
differences were found between control and TL2937-treated
PIE cells after the challenge with DSS when caspase 3/7 was
evaluated (Figure 6D).
L. jensenii TL2937 Differentially Regulates
DSS-Triggered Transcriptomic Response in
Epithelial Cells
The transcriptomic response of PIE cells to the challenge
with DSS and the effect of L. jensenii TL2937 in that response
were evaluated by microarray analysis. When DSS-treated PIE
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FIGURE 7 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the immunotranscriptomic response of intestinal epithelial cells induced by dextran sodium
sulfate (DSS) administration. Porcine intestinal epithelial (PIE) were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h and then challenged with 0.01% DSS
for 6 h. PIE cells challenged only with DSS were used as controls. The expression of differentially regulated genes with immune-related functions was evaluated by
microarray analysis. (A) Venn diagrams showing the number of differentially upregulated and downregulated genes with immune-related functions for each
experimental group. (B) PPI network and (C) heat-map analysis of genes with immune-related functions.
cells were compared with unchallenged cells, it was found
that there were 243 and 327 unique transcripts upregulated
and downregulated, respectively (Supplementary Figure 1A).
Out of these differentially regulated genes, several were
assigned to immune-related functions according to the
PPI network (Supplementary Figure 1B) and GO database
(Supplementary Figure 1C) analysis. The PPI network is
a hierarchical structure, where the Hubs show the factors
that play a central role in directing cellular response to a
given stimulus. Then, to identify the regulatory Hub genes
involved in the transcriptome network of TL2937-treated
PIE cells after the challenge with DSS, we constructed
and visualized the PPI network of differentially expressed
transcripts (Supplementary Figure 1B). The centrality measures
(degree and betweenness) indicated that UBC, UBQLN4,
PTN, ALB, IL2, ONECUT1, VTN, TTR, IFR5, APP, NUP214,
RARB, FGFR2, TF, FOXO4, AMBP, DAB2, GRB2, CFH, and
SMAD3 were the major Hub genes of the L. jensenii TL2937-
mediated transcriptional network in the DSS-treated PIE
cells (Supplementary Figure 1B; Supplementary Table 3).
The changes of immunotranscriptome response in PIE cells
after DSS challenge included genes in the following GO
Biological Process pathways: “Response to stimulus,” “Regulation
of response to stimulus,” “Cell surface receptor signaling
pathway,” “response to stress,” “Defense response,” “Regulation
of immune system process,” “Regulation of cytokine production,”
“Regulation of cell adhesion,” and “Regulation of MAPK cascade”
(Supplementary Figure 1C).
Immune-related genes were found in both upregulated
(37 unique genes) and downregulated (37 unique genes)
transcript groups (Figure 7A). In order to identify the major
immunoregulatory Hub genes involved in the transcriptomic
network of TL2937-treated PIE cells after the challenge with DSS,
we constructed and visualized the PPI network of differentially
expressed immune related genes (Figure 7B). The network
displayed that MAPK13, CD80, CD274, CD8B, CD40, CD4, F2R,
F3, OAS1, IRF5, FGFR2, IL2RG, AMBP, IL2, IL1A, SELE, and
CXCL10 were upregulated among the regulatory Hubs. While
NOS2, IL16, EPCAM, CADM3, GDF15, IL12RB1, CD28, CD209,
FGG, CXCR4, TGFA, MPO, NCF2, CSF3, CCL5, and CXCL13
were downregulated in PIE cells among the regulatory Hub genes
of the immunotranscriptomic networks (Figure 7B). Significant
differences were observed in the immunotranscriptomic
responses when TL2937-treated PIE cells were compared with
DSS controls (Figure 7C; Supplementary Table 4). The most
remarkable changes in TL2937-treated PIE cells after stimulation
with DSS were found in expression cytokines, chemokines, and
adhesion molecules.
L. jensenii TL2937 Differentially Regulates
the DSS-Triggered Inflammatory Response
in Epithelial Cells
To further evaluate gene expression changes induced by DSS
in PIE cells, qRT-PCR was performed. From the immune
and immune-related genes differentially regulated by DSS
in the microarray analysis, we selected 25 belonging to
cytokines, chemokines (Figure 8), and adhesion molecules
(Figure 9A) groups as well as NCF1, NCF2, NOS2,
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FIGURE 8 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the immunotranscriptomic response of intestinal epithelial cells induced by dextran sodium
sulfate (DSS) administration. Porcine intestinal epithelia (PIE) were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h and then challenged with 0.01% DSS
for 6 h. PIE cells challenged only with DSS were used as controls. The expression levels of TNF-α, IL-1α, IL-1β, IL-6, IL-15, TFF2, TGF-β, CCL2, CCL4, CCL8,
CCL11, CXCL5, CXCL8, CXCL9, and CXCL10 were determined by qRT-PCR. The results represent three independent experiments. Significant differences when
compared to the DSS control group: *P < 0.05, **P < 0.01.
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FIGURE 9 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the immunotranscriptomic response of intestinal epithelial cells induced by dextran sodium
sulfate (DSS) administration. Porcine intestinal epithelial (PIE) were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h, and then challenged with 0.01% DSS
for 6 h. PIE cells challenged only with DSS were used as controls. The expression levels of adhesion molecules (A) SELE, SELL, VCAM, EPCAM, and inflammatory
factors (B) NCF1, NCF2, NOS2, c, PPARα, and SAA2 were determined by qRT-PCR. The results PPAR represent three independent experiments. Significant
differences when compared to the DSS control group: *P < 0.05, **P < 0.01.
PPARγ c, PPARα, and SAA2 (Figure 9B) to be studied
by qRT-PCR.
The challenge of PIE cell with DSS significantly increased the
expression of TNF-α, IL-1α, IL-1β , IL-6, IL-15, and TFF2 when
compared to unchallenged cells (Figure 8). DSS stimulation also
induced a remarkable increase in the expression of CCL4, CCL8,
CXCL5, CXCL9, and CXCL10 as well as modest but significant
increases in CCL2 and CCL11 (Figure 8). Of note, TL2937-
treated PIE cells showed expression values of these cytokines and
chemokines (Figure 8) that were lower than the DSS control cells
and were similar to those found in unchallenged PIE cells. In our
hands, no significant variations in the expression of TGF-β and
CXCL8 were found when the different experimental groups were
compared to unchallenged PIE cells.
As shown in Figure 9A, significant higher expression levels of
SELL, SELE, and EPCAM were found when PIE cells stimulated
with DSS were compared to unchallenged cells. The expression
levels of those adhesion molecules in TL2937-treated PIE cells
were lower than the DSS controls and were similar to those
observed in unchallenged PIE cells. No significant variations
in the expression of VCAM were found when the different
experimental groups were compared to unchallenged PIE cells.
DSS stimulation induced increases in the expression levels
of NCF1, NCF2, NOS2, PPARα, and SAA2 (Figure 9B). Lower
expression levels of these factors were found in TL2937-treated
PIE cells when compared the DSS control cells. Moreover, the
expression levels were similar to those found in unchallenged PIE
cells (Figure 9B). No significant variations in the expression of
PPARγ cwere foundwhen the different experimental groups were
compared to unchallenged PIE cells (Figure 9B).
In order to confirm the immunomodulatory effect of the
TL2937 strain on IECs and validate our PIE cell system as a
potential human model, we performed experiments in human
Caco-2 cells (29). For this purpose, Caco-2 cells were treated
with L. jensenii TL2937, challenged with 1% DSS, and the
levels of TNF-α, IL-1β, IL-6, and IL-8 were measured in culture
supernatants (Figure 10). The challenge of Caco-2 cells with
DSS significantly increased the levels of the four cytokines when
compared to unchallenged cells. Of note, the levels of TNF-α,
IL-1β, IL-6, and IL-8 were significantly reduced in lactobacilli-
treated cells when compared to DSS controls.
DISCUSSION
The regulation of the cytokine networks that control the
intestinal epithelial barrier function and the mucosal immune
system has emerged as an interesting alternative for IBD
treatment (1, 2, 4). Moreover, the great progress in the
understanding of how beneficial microbes are able to
modulate mucosal cytokines has allowed the selection and
characterization of immunobiotic candidates for alleviating
intestinal inflammation in IBD patients (12, 13). In this work,
by using a DSS-induced colitis in the mouse model, we have
demonstrated for the first time the ability of the immunobiotic
strain L. jensenii TL2937 to protect the intestinal epithelium
from the inflammatory damage through the regulation of the
intestinal cytokine network.
In our hands, the administration of L. jensenii TL2937 before
the challenge of mice with DSS achieved the protective effect. In
fact, the preventive administration (PRE DSS+TL2937 group)
or the one that started before and then was administered
simultaneously with DSS (CONT DSS+TL2937 group) showed
the ability to improve the general health status of animals and
to reduce intestinal disorders mediated by the inflammatory
response. Those beneficial effects were not observed when the
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FIGURE 10 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the inflammatory cytokine production by human colon Caco-2 cells induced by dextran sodium
sulfate (DSS) administration. Caco-2 cells were stimulated with L. jensenii TL2937 (5 × 107 cells/ml) for 48 h and then challenged with 1% DSS for 48 h. Caco-2 cells
challenged only with DSS were used as controls. The levels of TNF-α, IL-1β, IL-6, and IL-8 were determined by ELISA. The results represent three independent
experiments. Significant differences when compared to the DSS control group: *P < 0.05, **P < 0.01.
immunobiotic bacteria were administered only simultaneously
with DSS (SIM DSS+TL2937 group). Our results are in line
with several other reports that have indicated that immunobiotic
preventive treatments are more effective to alleviate the
symptoms of colitis than their administration during acute active
inflammatory phases [reviewed in (12)]. For example, it was
reported that the preventive treatment with Bifidobacterium
breve NCC2950 significantly diminished the severity of DSS-
induced colitis, IEC damage, and MPO activity by the regulation
of pro- and anti-inflammatory cytokine balance, while the
administration of this strain during active DSS colitis was
not effective to control inflammation (42). Similarly, only the
preventive administration of TL2937 strain was able to improve
body weight gain, diminish DAI and clinical score values, reduce
the alterations of colon length and the colon length:weight
ratio, and diminish intestinal MPO activity. Moreover, our
results evidenced a remarkable capacity of L. jensenii TL2937
to differentially regulate the intestinal cytokine profile in DSS-
challenged mice.
The concentrations of TNF-α, IL-1β, IL-6, IFN-γ, and IL-17
were significantly lower in the colon of L. jensenii TL2937-treated
mice than in the DSS control group. All these inflammatory
cytokines have been implicated in the pathogenesis of IBD.
Earlier studies demonstrated the detrimental effects of TNF-α
in IBD and that the blockade of this cytokine was effective in
ameliorating the severity of colitis in both the T cell transfer (43)
and the DSS mouse models (44). It was also reported that the
excessive production of TNF-α weakened the intestinal epithelial
barrier function by altering IEC integrity and inducing their
apoptosis (45, 46). The interaction of TNF-α with the receptors
TNFR1 and TNFR2 stimulates the expression of inflammatory
factors through NF-κB activation, induces damage of IECs via
myosin light chain kinase (MLCK) activation (47), and stimulates
cell death through receptor-interacting protein kinase 1 (RIPK1)
and caspase protein activation (48). Moreover, a plethora of
effects have been attributed to TNF-α during the generation
and development of IBD including the induction of death in
Paneth cells, the increase in angiogenesis, the enhancement of
matrix metalloproteinase production, and the potentiation of
inflammation by the stimulation of immune cells (48). On the
other hand, although IL-6 is of importance for the maintenance
of the normal barrier function of the intestinal epithelium (49),
deregulated production of IL-6 in the gut promotes T cell
expansion and stimulates Th1 cell-mediated inflammation (50).
It was also demonstrated that the deletion of the inflammasome
component caspase-1 that is involved in the production of the
active forms of IL-1β and IL-18 (51) or the blockade of IL-1β
or IL-18 signaling (52, 53) significantly attenuates the severity of
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FIGURE 11 | Effect of immunobiotic Lactobacillus jensenii TL2937 on the immunotranscriptomic response of intestinal epithelial cells induced by dextran sodium
sulfate (DSS) administration. Global overview of the signaling pathways and immune genes differentially regulated in porcine intestinal epithelial (PIE) cells after the
challenge with DSS. Global overview of the signaling pathways and immune genes differentially regulated in PIE cells treated with L. jensenii TL2937 and challenged
with DSS.
DSS-induced colitis in mice. In addition, IL-1β is able to promote
intestinal inflammatory damage by collaborating in the activation
and differentiation of T cells that produce IL-17 or IFN-γ (54),
which are increased and are highly active in the intestinal mucosa
of IBD patients (1, 2). On the other hand, it was found that IL-10
and IL-27 were significantly higher in L. jensenii TL2937-treated
mice than in the DSS control group while no differences between
the groups were observed for colon TGF-β concentrations. It
was shown that mice deficient in either IL-10 or its receptor IL-
10R develop spontaneous colitis (55, 56). Furthermore, genetic
studies evaluating IL-10 found that some mutations in the genes
encoding IL-10 or IL-10R are associated with an early onset
of IBD development in children (57) while deficiencies in IL-
10 have been associated with pathogenic responses of IL-12-
and IL-23-producing T cells in several models of colitis (2).
It was also shown that the alterations in both IL-35 and IL-
27 exacerbate T cell transfer colitis (58). Then, the results of
this work indicate that L. jensenii TL2937 is able to induce
a differential cytokine balance in response to DSS stimulation
by decreasing the production of inflammatory cytokines and
increasing the levels of regulatory cytokines. This differential
profile could be related to a direct effect of the immunobiotic
strain on cytokine production, as observed on day −4 for IL-10
and IL-27, as well as an indirect effect due to the protection of
the intestinal epithelium against the damage that decreases the
activation of the innate immune response.
The murine model of DSS-induced colitis is particularly
useful for the evaluation of the role of both intestinal barrier
and the innate immune responses in the context of IBD
(12). In this mouse model, the administration of DSS in the
drinking water induces damage on IECs causing alterations in
the barrier functions of the surface epithelium and allowing
the passage of lumen antigens that strongly stimulate the
innate immune system. Then, considering the in vivo studies
performed here demonstrating the ability of L. jensenii TL2937
to protect mice against DSS challenge, we hypothesized that the
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immunobiotic strain would exert its beneficial effects, at least
partially, through the modulation of IEC physiology. In fact,
our experiments evaluating the expression of tight junction and
adherens junction genes in vivo, includingOcln,ZO-1,Cldn1, and
Ctnn, demonstrated the ability of L. jenseniiTL2937 to strengthen
the barrier function of IECs. Then, detailed in vitro studies were
performed by using the PIE cell line and DSS stimulation.
When the effect of L. jensenii TL2937 on the
immunotranscriptome response of DSS-challenged PIE cells
was evaluated, the most remarkable differences were found
in the expression of inflammatory cytokines and chemokines
(Figure 11). Significantly reduced expression levels of TNF-α,
IL-1α, IL-1β , IL-6, and IL-15 were found in DSS-challenged
PIE cells previously stimulated with the TL2937 strain, which
showed a strong correlation with our in vivo findings in mice
and with our studies in human Caco-2 cells. In addition to
inflammatory cytokines, IECs are able to secrete chemokines
and express adhesion molecules in response to injury, and in
this way, these cells play an active role in shaping the nature of
the intestinal immune response. It was shown that the chronic
intestinal inflammation of IBD is driven and sustained in part
by an increased production of chemokines from the inflamed
epithelium (59). In this work, the challenge of PIE cells with
DSS significantly increased their expression of CCL2, CCL4,
CCL8, CXCL5, CXCL9, and CXCL10 as well as the adhesion
molecules SELL, SELE, and EPCAM, highlighting the role of
inflamed IECs in the recruitment and activation of leukocytes
in the intestinal mucosa. Of note, most of the chemokines and
adhesion molecules evaluated were lower in TL2937-treated PIE
cells when compared to DSS control. Although we have not
performed a detailed evaluation of chemokines and adhesion
molecules in the DSS mouse model, we observed a significant
reduction in the levels of CXCL1, MCP-1, IL-15, and MPO in
the colon of TL2937-treated mice. It is tempting to speculate
that L. jensenii TL2937 would be able to beneficially modulate
chemokines and adhesion molecules in vivo. It would be
of value to evaluate the effect of the immunobiotic TL2937
strain on the recruitment and activation of leukocytes in
the intestinal mucosa, and the connection of this effect to
the protection against the intestinal damage. This could lay
the scientific basis for the application of this strain in other
inflammatory-based pathologies.
The cytokines produced by IECs and cells in the surrounding
microenvironment are key players in the control of themigration,
differentiation, and survival of IECs. The closure of erosions and
ulcers in the intestinal mucosa is promoted by the proliferation
and expansion of IECs and is critically dependent on intestinal
cytokine networks (60, 61). Studies have found that increased
apoptosis of IECs in the inflamed mucosa of IBD patients
and the overproduction of inflammatory cytokines have been
associated with the destruction of intestinal epithelial layers
by promoting apoptotic death in IECs (62). Moreover, some
inflammatory cytokines such as TNF-α and IFN-γ are able
to alter the molecular bonds between the IECs reducing the
epithelial barrier function and aggravating the epithelial erosions
(47, 63). Here, we were able to reproduce in vitro those relevant
characteristics of the intestinal mucosa of IBD patients. In our
hands, DSS administration to PIE cells significantly increased
the numbers of apoptotic cells and diminished the TER index.
Moreover, in line with our results in mice challenged with DSS,
PIE cells had an altered expression and distribution of ZO-
1 and β-catenin, indicating a clear alteration of the epithelial
barrier. Interestingly, L. jensenii TL2937 was able to significantly
reduce the alterations of all these parameters in DSS-challenged
PIE cells. As mentioned earlier, the phosphorylation of JNK
in the intestinal epithelium has been linked to some cellular
and molecular changes that are characteristic of IBD. JNK
pathway activation is related the expression of TNF-α (40), the
reduction of tight junctions strength (39), and the induction
of apoptosis (41). In our in vitro model, a clear activation of
the JNK pathway was observed in PIE cells after the challenge
with DSS. Moreover, we found that L. jensenii TL2937 was
able to differentially modulate the activation of this pathway,
since an earlier and lower increase in p-JNK levels and lower
intracellular Ca2+ fluxes were detected in this group. Previously,
we evaluated the interaction of L. jensenii TL2937 with PIE cells
and demonstrated that this bacterium is able to interact with
TLR2 and upregulate the expression of negative regulators of
the TLR signaling pathway (17). In this way, this immunobiotic
strain modulates the subsequent TLR4 activation by reducing
the activation of NF-κB and p38 signaling pathways, and the
expression of inflammatory cytokines and chemokines. It is
tempting to speculate that in the context of DSS stimulation, the
upregulation of negative regulators induced by the TL2937 strain
would allow the regulation of the JNK pathway and significantly
impact in the immunotranscriptomic response, apoptosis, and
barrier functions of PIE cells.
Because of the anatomical, physiological, and immunological
similarities of human and porcine intestine, pigs have been
considered an attractive model to study the mechanisms involved
in intestinal diseases as well as the interaction of microbes with
the immune system (64). In this work, we demonstrated that
PIE cells could give us the possibility of conducting in vitro
studies to evaluate the epithelial barrier function, the innate
immune response, and the influence of immunomodulatory
beneficial microbes on those parameters, in the context of DSS
challenge. Our statement is supported by the good correlation
found in the modulation of cytokines and chemokines by
L. jensenii TL2937 in the in vivo mouse model and the in
vitro PIE cell system. Moreover, we also found that the TL2937
strain was capable of reducing the production of inflammatory
cytokines and chemokines in human Caco-2 cells in response
to DSS, resembling the results observed in PIE cells. Caco-2
monolayers have been successfully used for the evaluation of
therapeutic alternatives on the barrier integrity, inflammation,
and cell death in response to DSS (29, 65–67). Then, our
comparative in vitro results reinforce the scientific basis for
proposing PIE cells as a good in vitro model for molecular
studies of IBD. Further comparative studies that involve the
use of lactobacilli that do not have beneficial effects on the
inflammatory response and/or the epithelial barrier in IBD
models would be of great importance to position our in vitro
system as a useful tool in the selection of potential probiotics for
UC or CD.
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CONCLUSIONS
The findings of this work allow us to arrive at three main
conclusions: (a) L. jensenii TL2937 is able to alleviate DSS-
induced colitis through the regulation of intestinal cytokine
networks suggesting a potential novel application for this
immunobiotic strain in the context of IBD. Furthermore, (b) the
modulation of the transcriptomic response of IECs by the TL2937
strain would play a key role in this beneficial effect. Although
a remarkable effect of L. jensenii TL2937 on IECs was observed
here, further studies are needed to characterize the mechanisms
involved in the protection against DSS colitis induced by this
immunobiotic strain. For example, it is known that IECs are not
efficient producers of IL-10 or IL-27, two cytokines that were
augmented in mice treated with L. jensenii TL2937. Then, the
study of the cellular and molecular interactions of the TL2937
strain with intestinal macrophages or DCs would be of value to
explain the increases of the regulatory cytokines. In addition,
we demonstrated that (c) the in vitro PIE cell immunoassay
system could be of value for the screening and selection of new
immunobiotic strains for their application in IBD. Although
murine models have been of great value to select and characterize
immunobiotics for IBD, the reduction of animals being used in
experiments has become a central topic of debate in the scientific
community (68). The good correlation between the alterations
of barrier function, epithelial cell death, and cytokine networks
found in previous in vitro and in vivo IBD models and our in
vitro findings in PIE cells show the potential value of our system
to select efficiently new immunobiotic candidates for CD or UC.
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